Price $71.79 |
Market Cap
3.66B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
61.4
|
P/B
5.73
|
P/S
8.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
75.1
|
Op. Cash Flow
63.8K
|
FCF
0.9
|
|
Op. Margin
16.70%
|
Net Margin
14.50%
|
ROE
9.90%
|
ROI
8.80%
|
|
ROA
9.00%
|
EPS Growth
-5.80%
|
Current Ratio
11.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $22.10 | - | - | 8.35B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 12.3M | Strong Buy |
| Hologic, Inc. (HOLX) | $49.85 | - | - | 13.59B | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.92 | - | - | 33.8M | Strong Buy |
| American Renal Associates Hold (ARA) | $6.64 | - | - | 240.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
